Despite the recent decline in M&A transactions in Q1 2018, activity is expected to ramp up in the second half of 2018. After two years of intense consolidation in the CDMO industry, companies are finding that in order to be successful, they must find new ways to add value. In an attempt to stand out against competition, CDMOs are evolving their businesses to expand beyond core capabilities while moving into adjacent categories.
This Market Insight report examines the dynamic CDMO market landscape and recent M&A activity in the sector.
Read our 2018 Market Insight on the PBM Specialty Pharmacy Industry here.